Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial (Q46977957)

27 December 2017

title

Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial (English)

1 reference

27 December 2017

multicenter clinical trial

main subject

phase III clinical trial

0 references

1 reference

1 reference

Peter J Hutchinson

4

0 references

Gordon Murray

object named as

Gordon D Murray

5

0 references

author name string

Peter J Kirkpatrick

1

1 reference

27 December 2017

Carole L Turner

2

1 reference

27 December 2017

Christopher Smith

3

1 reference

27 December 2017

STASH Collaborators

6

1 reference

27 December 2017

publication date

15 May 2014

1 reference

27 December 2017

published in

Lancet Neurology

1 reference

27 December 2017

volume

13

1 reference

27 December 2017

page(s)

666-675

1 reference

27 December 2017

issue

7

1 reference

27 December 2017

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Epidemiology of Aneurysmal Subarachnoid Hemorrhage in Australia and New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Delayed neurological deterioration after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Cerebral vasospasm pharmacological treatment: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Subarachnoid haemorrhage: diagnosis, causes and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Statins and anti-inflammatory therapies for subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Vascular effects of statins in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Neuroprotective properties of statins in cerebral ischemia and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

Causes of neurological deficits following clipping of 200 consecutive ruptured aneurysms in patients with good-grade aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970084-5

7 January 2021

10.1016/S1474-4422(14)70084-5

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

24837690

1 reference

27 December 2017